Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 17.07 CNY 0.41%
Market Cap: 28.5B CNY
Have any thoughts about
Shijiazhuang Yiling Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shijiazhuang Yiling Pharmaceutical Co Ltd

Current Assets 6.5B
Cash & Short-Term Investments 1.2B
Receivables 3.2B
Other Current Assets 2.2B
Non-Current Assets 10.4B
Long-Term Investments 1.7B
PP&E 7.5B
Intangibles 1B
Other Non-Current Assets 167.1m
Current Liabilities 4.4B
Accounts Payable 1.9B
Accrued Liabilities 333.4m
Short-Term Debt 1.1B
Other Current Liabilities 1B
Non-Current Liabilities 1.1B
Long-Term Debt 620.1m
Other Non-Current Liabilities 478m

Balance Sheet
Shijiazhuang Yiling Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
402
430
548
802
777
713
1 234
953
1 811
847
Cash
2
2
1
1
0
1
1
953
1 811
847
Cash Equivalents
400
428
547
801
777
712
1 233
0
0
0
Short-Term Investments
0
0
0
0
705
293
217
55
518
206
Total Receivables
438
658
890
1 308
2 010
2 466
1 956
2 615
2 292
2 735
Accounts Receivables
240
335
464
689
619
1 117
1 133
1 611
1 727
2 401
Other Receivables
198
323
426
619
1 391
1 349
823
1 004
566
334
Inventory
834
1 038
928
1 076
1 176
1 222
1 580
1 673
2 022
2 459
Other Current Assets
569
196
163
960
231
374
472
306
611
298
Total Current Assets
2 242
2 322
2 528
4 147
4 898
5 068
5 459
5 602
7 254
6 544
PP&E Net
1 966
2 734
3 098
3 048
2 965
3 151
5 142
6 248
6 586
7 525
PP&E Gross
1 966
2 734
3 098
3 048
2 965
3 151
5 142
6 248
6 586
7 525
Accumulated Depreciation
377
503
702
935
1 145
1 357
1 576
1 882
2 267
2 751
Intangible Assets
379
467
516
538
562
754
737
898
828
929
Goodwill
0
0
0
12
0
0
0
0
0
116
Long-Term Investments
1
6
77
100
66
17
11
25
1 372
1 676
Other Long-Term Assets
500
179
38
43
66
78
143
132
298
191
Other Assets
0
0
0
12
0
0
0
0
0
116
Total Assets
5 088
N/A
5 707
+12%
6 258
+10%
7 887
+26%
8 557
+8%
9 069
+6%
11 492
+27%
12 905
+12%
16 338
+27%
16 979
+4%
Liabilities
Accounts Payable
247
373
312
353
389
507
990
1 560
1 480
2 124
Accrued Liabilities
21
37
106
90
112
147
261
263
654
411
Short-Term Debt
0
50
100
0
0
50
468
764
1 081
1 323
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
13
156
207
Other Current Liabilities
236
247
230
164
264
102
520
361
1 479
383
Total Current Liabilities
505
707
748
607
765
806
2 239
2 960
4 850
4 447
Long-Term Debt
0
0
0
0
0
0
0
513
215
612
Deferred Income Tax
0
0
0
0
0
0
2
1
8
130
Minority Interest
0
12
11
2
3
8
4
3
2
12
Other Liabilities
167
172
177
168
229
310
328
358
335
352
Total Liabilities
671
N/A
891
+33%
936
+5%
777
-17%
996
+28%
1 125
+13%
2 573
+129%
3 836
+49%
5 406
+41%
5 530
+2%
Equity
Common Stock
563
1 128
1 129
1 205
1 206
1 204
1 204
1 671
1 671
1 671
Retained Earnings
1 757
2 131
2 549
2 969
3 448
3 935
4 915
5 065
6 926
7 443
Additional Paid In Capital
2 234
1 691
1 714
2 941
2 957
2 932
2 932
2 343
2 343
2 343
Treasury Stock
137
135
67
0
47
122
122
0
0
0
Other Equity
0
0
3
5
4
4
9
10
7
7
Total Equity
4 417
N/A
4 816
+9%
5 322
+11%
7 110
+34%
7 561
+6%
7 944
+5%
8 919
+12%
9 069
+2%
10 932
+21%
11 450
+5%
Total Liabilities & Equity
5 088
N/A
5 707
+12%
6 258
+10%
7 887
+26%
8 557
+8%
9 069
+6%
11 492
+27%
12 905
+12%
16 338
+27%
16 979
+4%
Shares Outstanding
Common Shares Outstanding
1 127
1 128
1 129
1 205
1 206
1 204
1 204
1 671
1 671
1 671

See Also

Discover More